{"title": "PDF", "author": "PDF", "url": "https://www.broadinstitute.org/files/patents/WO2019014581A1.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "andphenotype limitation, aerosols, affinity separation, magnetic cell separation, microfluidic separation, thereof. Pharmaceutical Compositions usingIsolated fromagroupcomprising; mutated proteins, genetically engineered proteins, peptides, synthetic peptides, recombinant proteins, chimeric proteins, antibodies, midibodies, minibodies, 62/067,886, 23-Oct-14, DELIVERY, USEANDTHERAPEUTIC APPLICATIONS SYSTEMS and62/181,002, (e.g.,temperature) 4 3 331 1 8 3 7 3 4 9 5 6 3 8 8 9 Pogk 547 6 6 4 987 2 7 6 237 6 303 104.9 103.4 4 9 583 8 7 4 9 906 6 8 4 Edaradd 1.15 1.57 1.14 0.58 1.82 0.97 3.23 2.18 2.65 2.39 1.85 2.42 2.14 2.37 Als2 2.39 6.35 6.19 6 781 4 7 1601.4 6 328 2 5 6 1 3 159 4 1 07 9 2 5 207 9 9 3 6 8 2010002 M12Rik 1.04 1.51 1.35 0.97 1.31 1.35 2.06 2.66 2.22 1.88 Sgoll 0.09 0.13 1.03 0.5 0.05 0.09 1.54 9.6 0.44 2.87 1.4 1.97 2.57 1.81 Aqp9 0.35 1.82 1.81 0.67 1.46 0.69 13.7 Birc5 1.71 2.58 0.46 8 8 809 2 9 8 482 9 3 2 110.2 3 9 3 1 7191.3 5 9 Ttc39c 0 0.17 0.07 0.14 7 8 121 5 9 5 198 6 9 9 136.4 6151.8 84 6 2 3 Diapl 5.6 6 2 213 9 3 2 406 9 1 6 28.1 2 3 6 388 1 5 8 Dennd5a 3 5 8 175 8 2 2 Mier3 1.91 1.68 2.11 1.89 2.14 3.6 4.08 1 4 8 4 975 1 2 4 7 9 8 2 8 24.4 21.4 5 3 9 6221.3 1 3 993 1 5 5 2 303 5 5224.4 Cnih4 51 8 4 8 955 4 3 3 3 7 745 6 6 4 863 2 6 2 7 8 12.4 N6amt2 8 337 2 6 9 4 9 2 3 7 3 1 383 2 2 9 899 5 6 1 29.9 7 5 347 6 4 8 959 1 6 8 142.4 3 3 104 8 8 9 9 0 0 0 00.04 0.25 0.59 3.98 0.13 Hfe 0 0 0 0.97 4 125 4 4 4 3 7 1 2 4 35.9 8 2 5 2 99.57 6 8 7 428 7 1 7 955 9 8 635 6 7 6 4415 9 9 1.18 Taptl 10.13 14.24 9.48 15.85 11.09 7.61 5.85 4 5 1 714 6 4 4 51682.83 3 4 12.8 3 4 7 994 6 6 3 4 837 6 5 4 793 2 3 9 4 9 743 8 8 7 639 2 1 6 8483 423 3 1 6 2 232 4 6 7 572 6 4 5 213.0 6.05 6.35.69 5.91 19.76 4.15 3.25 1.89 4.15 2.93.71 1.38 2.25 1.19 Fchsd2 10.08 7.16 7.07 11.07 25.5 8.77 6.67 3.73 3.67 3.69 3.98 7.37 4.51 3.31 3.32 8 7 1 607 2 5 5 Abll 6 6 7 1 0 Smadl 0.56 1.68 1.65 8 9 5.Iamf7- 1 117.1 7 497.591.66 52.83 Zfp395 1.32 1.98 1.43 3.25 5.62.33 0.97 2.22 4.93 0.92 1.56 0.59 1.05 0 ZbtblO 3.02 2.09 1.92 1.71 4.5 2.1 1.3 0.4 2.79 0.76 0.53 0.63 0.09 0.32 Ldlrad4 10.32 6 3 3 4 105 1 9 1 Prrg4 5.45 4.61.72 3.4 8.2 3.5 1.11 1.28 1.08 0.84 Taf4b 7.68 8.35 7.32 6.27 7.45 8.04 20.55 77.03 8 9 7 832 4 2 8 6 2 2 9 1 291 7 1391.5 335 8 7 1 1 7 9 557 2 2 5 982 9 7 8 3 3 7 3 9 241 9241.8 399.5 4 5 3 968 1 2 2 906 8 9 3 18.7 8 2 8 698 4 4 7 9 2 315 2 9 1 375 6 8 2 Mgat5 15.03 121.1 105.5 428 4 2 7 285 7 3 5 1928. 1955. 2 3 703 8 6 2.87 4.81 4.73 Ulk2 3.25 4.86 1.59 2.16 3.69 2.16 1.37 0.39 2.66 1.78 1.68 0.75 0.4 1.19 3.01 2.12 0.61 2.15 02.64 2.79 1.74 0 0 5.96 1.9 4.84 6.88 5.12 Csrnp2 1.01 2.9 2.28 2.53 73.1 Clqb 4.82 42.74 8.03 1.94 3.19 3.34 0.6 0.83 126.6 7 2 9 4 6 9 7 8 1 383 3 7 Limd2 3 8 9 9 216 6 4 1 975 9 4 4 48.5 36.7 Smap2 3 5 2 3 7 3 6 845 5 4 3 19.6 Brd8 19.72 20.65 12.86 2 7 762 2 4 1 548 Usp28 12.56 17.76 15.7 5.67 7.41 4.5 8.13 2.86 5.3 5.57 7.53 6.14 2.72 9.87 1.01 1.43 2.24 2.69 3.33 1.66 1.23 1.82 2.61 11.06 10.4 7.18 7.22 6.65 5.3 3.49 3.16 6 4 31.1 35.77 0.9 1.15 3.19 2.15 2.57 0.58 2.26 2.27 1.39 7.37 28.08 3.05 17.68 3.07 Pira2 0 0 0 0.18 Lgals7 0 0.63 2.94 0.29 0.91 16.01 2.71 5.24 0.06 Lama5 0.05 0.2 0.07 0.29 0 2.1 0.05 Pcsk9 0.26 4.61 2.82 2.85 10.77 8.56 7.1 0.39 0.09 0.08 0.15 0 5.86 1.15 0.05 Syngrl 0.07 0 0 0.07 0.22 4.92 1.09 0.24 Rbpms2 0.47 1.44 0 1.62 2.04 0.68 0.49 Triml6 0.24 0.45 1.17 Cdl<16 6.22 3.9 1.1 4.12 3.98 2.6 Itga6 1.15 1.34 1.52 0.75 2.5 8.9 8.07 0.71 Parva 0.04 0.33 2.93 1.6 0 0.6 0.44 0.68 8.18 7.57 0.75 Gcnt4 0.07 0 0 0.03 0.11 2.79 2.41 0.06 0 0.06 0 1.04 0.55 0.04 Btc 0.35 0.07 0 0 0.02 1.87 1.39 0 Cdh2 0 0 0 0.11 0.08 4.88 3.2 0.13 Deptor 0 0 0 0 0 3.18 2.21 0.23 Epn2 0.35 0.84 0.23 1.61 0 7.1 5.52 0.89 Ltbp4 0.32 1.01 0 0.91 0.28 7.51 4.79 0.91 tkn 1.44 0.26 0 0.4 0 8.4 4.33 1.38 2.2 1.42 1.53 2.38 19.57 13.12 2.5 2.85 3.61 2.02 1.9 0.69 8.04 2.3 4.46 2.82 0.19 0 0 Slc43a2 2.33 5.63 1.55 2.9 2.38 0.85 1.1 1.12 Gpr34 4.59 12.2 2.61 8.15 9.44 1.11 0 0.1 Ganc 3.33 Nek8 8 6.5 7.91 7.62 3.51 9.53 4.25 7.63 8.61 0 St8sial 4.88 Myb 5.61 2.33 5.8 5.42 4.93 0.85 1.38 0 0 0 21.6 7.24 3.22 2.11 1.5 Wdr4 9.3 4.99 8.62 7.32 1.65 3.01 1.53 1.64 1.25 Ccdcl62 1.28 2.53 2.9 4.79 0.99 0 0.15 0 Myzap 0.73 1.48 2.66 4.39 0.48 0 1.14 1.23 1.06 Nucb2 12.74 12.27 34.21 36 6.21 5.85 3.55 1.41 Rnfl22 4.24 4.25 7.36 0.94 Srgap3 2015) "}